Trump reclassifies cannabis to Schedule III, easing restrictions on marijuana
US President Donald Trump sits in the Oval Office to sign executive orders, at the White House in Washington, DC,…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
World news in brief: Progress in fighting hunger in Asia and the Pacific, repair of key Gaza pipeline and flu hit Europe hard
The prevalence of malnutrition in the region decreased to 6.4 percent in 2024, down from seven percent in 2023, marking…
Medline Debuts on Nasdaq After Largest IPO of 2025
Shares of the American medical supply giant Medline jumped in its debut on the Nasdaq on Wednesday after the largest…
World news in brief: Statement on historic illnesses and mental health, hunger in Afghanistan deepens, refugee crisis in the Democratic Republic of the Congo
The agreement marks the first time governments have committed to tackling chronic diseases (such as heart disease, cancer and diabetes)…
Anti-obesity pills from Novo Nordisk and Eli Lilly arrive
Daniel Grill tetra images | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
New flu variant emerging, but vaccination remains our best option: WHO
Influenza and other respiratory viruses are on the rise, Dr. Wenqing Zhang, head of the Global Respiratory Threats Unit at…
Trump confirms possible drug reclassification, but stocks fall
Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on US President Joe Biden “to…
Why Wall Street and Jim Cramer Think Danaher Stock Is 'Ready to Play'
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…